Features

European data enforcers can’t make their fines stick

Nearly €80 million in fines levied by European data protection authorities have been dropped.

25 March 2021

UK data protection litigation analysis: the data and the gaps

GDR publishes the dataset that underpins its analysis of recent UK data protection litigation – and highlights how an opaque court system makes it tough to improve the data.

24 March 2021

Introducing the GDR Big Data Index

Aimed at providing insights on the market for data as an asset, GDR has created a weighted index tracking companies involved with adtech, AI, cloud storage, semiconductor manufacturing and other sectors related to big data.

22 March 2021

Big data thrived during a year of crises

Data has shown itself to be an increasingly valuable asset since covid-19 was declared a global pandemic one year ago, according to the GDR Big Data Index. Privacy laws, antitrust enforcement and other regulations could serve as headwinds in 2021.

22 March 2021

Searching for the exit: data considerations in early-stage investment

The days of ‘move fast and break things’ are long gone. Where fast-growing technology companies once prioritised growth and largely ignored collateral damage – including to data protection and privacy – today’s startups are taking a markedly more cautious approach to data risk.

22 March 2021

UK data protection litigation analysis: who’s getting sued?

GDR litigation data reveals which industries and sectors are bearing the brunt of data protection litigation – and confirms that the number of High Court cases has risen dramatically.

18 March 2021

UK data protection litigation analysis: the lawyers leading the way

Data compiled by GDR shows that a handful of firms are responsible for most recent data protection cases in England and Wales.

09 March 2021

UK data protection litigation analysis: class action uptake remains slow

Data compiled by GDR shows that much-hyped collective actions make up a tiny minority of UK data protection litigation.

08 March 2021

UK adequacy decision: end goal in sight

After years of wrangling over Brexit and the terms of the withdrawal agreement, recent squabbles over the importing of vaccines, shellfish and even ham sandwiches have made the issue of UK-EU equivalence a testy subject. As such, the European Commission’s recent UK adequacy decision is encouraging for the data community, says Kim Roberts of King & Spalding.

05 March 2021

What life sciences businesses need to know about data commercialisation

Data is playing an increasingly important part in life science commercial value creation, presenting new revenue-generating opportunities. A strategy for protecting and exploiting data is now a must for entities involved in healthcare research.

04 March 2021

Get unlimited access to all Global Data Review content